Nothing Special   »   [go: up one dir, main page]

SE8102558L - Immunologisk bestemmningsmetod - Google Patents

Immunologisk bestemmningsmetod

Info

Publication number
SE8102558L
SE8102558L SE8102558A SE8102558A SE8102558L SE 8102558 L SE8102558 L SE 8102558L SE 8102558 A SE8102558 A SE 8102558A SE 8102558 A SE8102558 A SE 8102558A SE 8102558 L SE8102558 L SE 8102558L
Authority
SE
Sweden
Prior art keywords
substance
immunologically active
determined
active reaction
immunological
Prior art date
Application number
SE8102558A
Other languages
Unknown language ( )
English (en)
Other versions
SE460930B (sv
Inventor
H Gallati
U Handschin
T Staehelin
C Stehli
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25692464&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8102558(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CH320980A external-priority patent/CH642458A5/de
Priority claimed from CH589880A external-priority patent/CH651396A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SE8102558L publication Critical patent/SE8102558L/sv
Publication of SE460930B publication Critical patent/SE460930B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
SE8102558A 1980-04-25 1981-04-22 Immunologiskt foerfarande foer bestaemning av en substans daer en av reaktionspartnerna aer bunden till en vattenoloeslig baerare SE460930B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH320980A CH642458A5 (en) 1980-04-25 1980-04-25 Immunological method
CH589880A CH651396A5 (en) 1980-08-04 1980-08-04 Immunological method for detecting and determining carcinoembryonic antigen

Publications (2)

Publication Number Publication Date
SE8102558L true SE8102558L (sv) 1981-10-26
SE460930B SE460930B (sv) 1989-12-04

Family

ID=25692464

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8102558A SE460930B (sv) 1980-04-25 1981-04-22 Immunologiskt foerfarande foer bestaemning av en substans daer en av reaktionspartnerna aer bunden till en vattenoloeslig baerare

Country Status (11)

Country Link
AT (1) AT373398B (sv)
AU (1) AU542563B2 (sv)
CA (1) CA1160566A (sv)
DE (1) DE3115115C2 (sv)
DK (1) DK151399C (sv)
FR (1) FR2481318A1 (sv)
GB (1) GB2074727B (sv)
IT (1) IT1137344B (sv)
NL (1) NL187545B (sv)
NO (1) NO159620C (sv)
SE (1) SE460930B (sv)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6406920B1 (en) 1980-06-20 2002-06-18 Inverness Medical Switzerland Gmbh Processes and apparatus for carrying out specific binding assays
EP0146654A3 (en) * 1980-06-20 1986-08-20 Unilever Plc Processes and apparatus for carrying out specific binding assays
EP0044219A1 (en) * 1980-07-16 1982-01-20 Unilever Plc Methods of immuno analysis using monoclonal antibodies
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
US4879219A (en) * 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
EP0049898B2 (en) * 1980-10-15 1991-08-14 Takeda Chemical Industries, Ltd. Method for immunochemical assay and kit therefor
US4837167A (en) * 1981-01-30 1989-06-06 Centocor, Inc. Immunoassay for multi-determinant antigens using high-affinity
GB2118300B (en) * 1982-02-12 1985-06-19 Corning Glass Works Method of immunoassay
DK76983A (da) * 1982-03-05 1983-09-06 Takeda Chemical Industries Ltd Fremgangsmaade og reagens til immunkemisk bestemmelse af humant choriogonadotropin
DE3225027A1 (de) * 1982-07-05 1984-01-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren
IL73938A (en) * 1984-01-02 1989-09-28 Boehringer Mannheim Gmbh Process and reagent for the determination of polyvalent antigen by incubation with three different receptors
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US5011771A (en) * 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4935339A (en) * 1985-05-07 1990-06-19 Nichols Institute Diagnostics Delayed solid phase immunologic assay
US5770459A (en) * 1986-04-30 1998-06-23 Igen International, Inc. Methods and apparatus for improved luminescence assays using particle concentration, electrochemical generation of chemiluminescence detection
DE3638767A1 (de) * 1986-11-13 1988-05-26 Behringwerke Ag Laktoferrin enthaltendes inkubationsmedium fuer festphasenimmunometrisches verfahren und seine verwendung
US5935779A (en) * 1988-11-03 1999-08-10 Igen International Inc. Methods for improved particle electrochemiluminescence assay
US6881589B1 (en) 1987-04-30 2005-04-19 Bioveris Corporation Electrochemiluminescent localizable complexes for assay compositions
US5190861A (en) * 1987-08-25 1993-03-02 Fuji Yakuhin Kogyo Kabushiki Kaisha Method for the diagnosis of rheumatoid arthritis
EP0339097B1 (en) * 1987-10-30 1994-08-03 Fuji Yakuhin Kogyo Kabushiki Kaisha Method for diagnosis of liver cancer
DE3807440A1 (de) * 1988-03-07 1989-09-21 Progen Biotechnik Gmbh Verfahren zum immunologischen nachweis von substanzen sowie eine derartige zusammensetzung und ein testkit
US5779976A (en) * 1988-11-03 1998-07-14 Igen International, Inc. Apparatus for improved luminescence assays
US5746974A (en) * 1988-11-03 1998-05-05 Igen International, Inc. Apparatus for improved luminescence assays using particle concentration, electrochemical generation of chemiluminescence and chemiluminescence detection
US5798083A (en) * 1988-11-03 1998-08-25 Igen International, Inc. Apparatus for improved luminescence assays using particle concentration and chemiluminescence detection
US5962218A (en) * 1988-11-03 1999-10-05 Igen International Inc. Methods and apparatus for improved luminescence assays
US5705402A (en) * 1988-11-03 1998-01-06 Igen International, Inc. Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
DE68928989T2 (de) * 1988-12-12 1999-09-30 Csl Ltd., Parkville Festphase-immuno-testverfahren mit etikettierten konjugaten
US5176999A (en) * 1989-12-07 1993-01-05 Eastman Kodak Company Buffered wash composition, insolubilizing composition, test kits and method of use
ZA92803B (en) 1991-02-06 1992-11-25 Igen Inc Method and apparatus for magnetic microparticulate based luminescene asay including plurality of magnets
US6201109B1 (en) 1993-01-13 2001-03-13 Dade Behring Marburg Gmbh Assay for bone alkaline phosphatase
FR2710410B1 (fr) * 1993-09-20 1995-10-20 Bio Merieux Procédé et dispositif pour la détermination d'un analyte dans un échantillon .
JP3694894B2 (ja) * 1994-02-19 2005-09-14 生化学工業株式会社 正常アグリカンの測定法および測定用キット
DE69928213T2 (de) 1998-09-01 2006-06-01 Taiho Pharmaceutical Co. Ltd. Methode zur bestimmung humaner thymidylat-synthase und kit dafür
US6844163B1 (en) 1999-04-12 2005-01-18 Sumitomo Chemical Co., Ltd. Method for analyzing the amount of intraabdominal adipose tissue
US8211279B2 (en) 2005-06-03 2012-07-03 Board Of Regents Of The University Of Texas System Electrochemistry and electrogenerated chemiluminescence with a single faradaic electrode

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572220A (en) * 1976-10-07 1980-07-30 Mochida Pharm Co Ltd Immunochemical process of measuring physiologically active substances
GB1549069A (en) * 1976-12-10 1979-08-01 Erba Farmitalia Enzyme linked immunoassay
US4244940A (en) * 1978-09-05 1981-01-13 Bio-Rad Laboratories, Inc. Single-incubation two-site immunoassay
GB2107053A (en) * 1980-06-20 1983-04-20 Unilever Plc Processes and apparatus for carrying out specific binding assays

Also Published As

Publication number Publication date
NL8101860A (nl) 1981-11-16
FR2481318B1 (sv) 1984-10-19
NL187545B (nl) 1991-06-03
NO811407L (no) 1981-10-26
DE3115115C2 (de) 1987-02-12
AU542563B2 (en) 1985-02-28
NO159620C (no) 1989-01-18
IT8121122A0 (it) 1981-04-13
ATA186481A (de) 1983-05-15
DK155881A (da) 1981-10-26
DK151399C (da) 1988-09-05
AT373398B (de) 1984-01-10
FR2481318A1 (fr) 1981-10-30
AU6981181A (en) 1981-10-29
SE460930B (sv) 1989-12-04
DE3115115A1 (de) 1982-02-04
NO159620B (no) 1988-10-10
IT1137344B (it) 1986-09-10
GB2074727A (en) 1981-11-04
DK151399B (da) 1987-11-30
CA1160566A (en) 1984-01-17
GB2074727B (en) 1983-11-30

Similar Documents

Publication Publication Date Title
SE8102558L (sv) Immunologisk bestemmningsmetod
ATE1614T1 (de) Immunologisches bestimmungsverfahren.
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
ATE14630T1 (de) Creatinin-antikoerper.
ES431413A1 (es) Metodo para detectar en muestras de plasma o suero sangui- neo la presencia de proteinas capaces de actuar como antige-nos o anticuerpos.
SE7904386L (sv) Biologisk provmetod med utnyttjande av fast fas
DE3576854D1 (de) Immunchemisches messverfahren fuer haptene und proteine.
DK516387A (da) Fremgangsmaade til immunometrisk bestemmelse
ATE80466T1 (de) Verfahren und reagenz zur bestimmung eines reaktionspartners einer immunologischen reaktion.
ATE67315T1 (de) Verfahren zur durchfuehrung von immunfluoreszenztesten.
FI854627A0 (fi) Foerfarande och reagens foer kvantitativ bestaemning av fri tyroxin i plasma, serum eller helblod.
DE3669078D1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
DE59207717D1 (de) Verfahren zur Bestimmung einer immunologisch bindefähigen Substanz
ES8401261A1 (es) Soportes de materia plastica revestidos de un segundo anticuerpo.
DE3568639D1 (en) Method for the determination of a substance capable of immunological binding
NO852058L (no) Fremgangsmaate og middel for bestemmelse av atl virus antistoffer.
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
DK439684D0 (da) Fremgangsmaade til immunokemisk bestemmelse af hepatitis b kerneantigener
ES8207221A1 (es) Un procedimiento inmunologico para la deteccion y determina-cion de una sustancia que posee al menos dos puntos unmuno- logicamente activos
JPS6454356A (en) Method for suppressing non-specific adsorption of antibody to solid phase antigen

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8102558-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8102558-7

Format of ref document f/p: F